TickerFacts.

Femasys Inc (FEMY): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$19.22M
Year ended 2025-12-31
-$18.07M
Trailing 12 months to 2026-06-30
2020-12-31: -$4.94M2021-12-31: -$8.24M2022-12-31: -$11.14M2023-12-31: -$11.42M2024-12-31: -$20.21M2025-12-31: -$19.22M-$19.22M
2020-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$19.22Mn/m2026-03-31, From 2025-01-01
2024-12-31-$20.21Mn/m2026-03-31, From 2024-01-01
2023-12-31-$11.42Mn/m2025-03-27, From 2023-01-01
2022-12-31-$11.14Mn/m2024-03-28, From 2022-01-01
2021-12-31-$8.24Mn/m2023-07-24, From 2021-01-01
2020-12-31-$4.94Mn/a2022-03-24, From 2020-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Femasys Inc (FEMY)2025-12-31-$19.22Mn/m
Vycor Medical Inc (VYCO)2025-12-31-$18.7Kn/m
EBR Systems, Inc. (NONE.)2025-12-31-$56.88Mn/m
Nuo Therapeutics, Inc. (AURX)2025-12-31-$1.14Mn/m
IceCure Medical Ltd. (ICCM)2025-12-31-$14.61Mn/m
Tenon Medical, Inc. (TNON)2025-12-31-$11.02Mn/m
Intelligent Bio Solutions Inc. (INBS)2026-06-30-$12.05Mn/m
PetVivo Holdings, Inc. (PETV)2026-03-31-$6.12Mn/m
RenovoRx, Inc. (RNXT)2025-12-31-$10.97Mn/m

Compare FEMY, VYCO, NONE., AURX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗